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1. Introduction 
Since the advent of prosthetic joint replacement, patients suffering from bone and joint 
pathology have benefited from significant improvements in mobility and pain relief. In 
Australia 39,200 hip replacements and 39,500 knee replacements were performed in 2009 
(Australian Orthopaedic Association National Joint Replacement Registry [AOA NJRR]) 
(Graves, et al. 2010). With an ageing population, the number of patients undergoing these 
procedures is projected to increase significantly over time. Data from the United States of 
America predicts that by 2030, the number of patients undergoing primary hip and knee 
replacement will increase by 174% and 673% respectively (Kurtz, et al. 2007). The major 
complication of such techniques is infection of the prosthetic device, which is associated 
with significant costs to individual patients and to the public health system. Significant 
morbidity is associated with prosthetic joint infections including the need for further 
operative procedures, long-term antibiotic therapy, and prolonged hospitalisation. 
Thereafter, the mortality rate from prosthetic joint infection is estimated to be between 1.0 to 
2.7 precent (Ahnfelt, et al. 1990, Zimmerli 2006, Zimmerli, et al. 2004). Aside from the effects 
on the individual patient, the financial cost to the health system is considerable. The 
estimated hospital costs is $ 96 166 (US) per patient requiring revision arthroplasty for 
infection, which is 4.8 times the cost of a primary arthroplasty(Bozic & Ries 2005). 
This chapter examines the underlying epidemiology, diagnosis, treatment and challenges in 
managing this problem. 
2. Epidemiology 
2.1 Incidence 
Identification of prosthetic joint infection currently relies on diagnostic criteria,  which 
include: histopathologic evidence of acute inflammation of periprosthetic tissue, presence of 
a sinus tract, macroscopic purulence surrounding the prosthesis observed intraoperatively 
or two or more positive microbiological cultures with the same organism isolated from the 
prosthetic joint fluid or tissue(Berbari, et al. 1998). We report a rate of prosthetic joint 
infection between 1.0 – 2.0% in primary lower limb arthroplasty and this is congruent with 
current literature (Dowsey & Choong 2008, 2009, Swan, et al. 2011). In the United States the 
rate of infection in knee and hip arthroplasty was 0.92% and 0.88% respectively in a recent 
review of Medicare data. (Kurtz, et al. 2008). The majority of arthroplasty infections occur in 
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the two years following prosthetic joint surgery. The incidence of knee arthroplasty infection 
within 2 years was 1.55% decreasing to 0.46% in the subsequent 8 years. Corresponding data 
in the hip arthroplasty population showed an incidence of 1.63% within 2 years and 0.59% 
between two to ten years (Kurtz, et al. 2010, Ong, et al. 2009)  
2.2 Risk factors 
A number of preoperative risk factors for prosthetic joint infection have been identified and 
these include pre-existing patient co-morbidities such as obesity, diabetes mellitus, 
rheumatoid arthritis and a history of prior malignancy. Body mass index (BMI) greater than 
40kg/m2 has been associated with a 9 fold increased risk of knee infection in our series 
(Dowsey & Choong 2009). Similar studies have shown that for every 1 kg/m2 increase in 
body mass index, there was an associated 8% increase in the risk of deep prosthetic joint 
infection. The association between obesity and deep prosthetic infections is particularly 
marked in the hip arthroplasty population with the risk of infection increasing from 0.9% in 
patients within the normal weight range, to 9.1% in morbidly obese(Choong, et al. 2007, 
Dowsey & Choong 2008). Diabetes mellitus also predisposes patients to deep prosthetic joint 
infection with 5.3% of diabetic patients developing a prosthetic joint infection in one study 
(Dowsey & Choong 2009, Yang, et al. 2001). Postulated mechanisms for the increased risk 
include impaired leucocyte function and impaired wound healing in diabetic patients. 
Rheumatoid arthritis has been associated with a higher risk of deep prosthetic joint 
infections. Patients with rheumatoid arthritis have been reported to have a greater than 2.5 
fold increase in the risk of arthroplasty infection compared to patients with osteoarthritis 
(Bengtson & Knutson 1991, Poss, et al. 1984). Whether this is due to impaired immunity 
secondary to the underlying disease or whether it is a reflection of the increased use of 
immunosuppressive medications in this cohort remains unclear (Berbari, et al. 2006b). A 
diagnosis of malignancy not involving the index joint has been identified as a risk factor for 
the subsequent development of prosthetic joint infection(Berbari, et al. 1998).  
Operative risk factors associated with deep prosthetic joint infection include higher 
American Society of Anaesthesiologist’s (ASA) and National Nosocomial Infections 
Surveillance (NNIS) scores, bilateral surgery, knee arthroplasty, arthroplasty type and 
operating room conditions. Berbari et al showed that increasing NNIS score was associated 
with increasing risk of deep prosthetic joint infection; NNIS score 1 was associated with a 
1.7 fold increase, increasing to 3.9 with a NNIS score of 2 (Berbari, et al. 1998). The ASA 
score, a component of the NNIS score, was also associated with an increased risk of 
arthroplasty infections (Pulido, et al. 2008). Pulido et al identified close to a six-fold increase 
in risk of prosthetic joint infection in patients undergoing simultaneous bilateral 
arthroplasty surgery. In the same study, knee arthroplasty, when compared to hip 
arthroplasty, was independently associated with a higher risk of developing deep prosthetic 
joint infection (Pulido, et al. 2008). The type of prosthesis used also appears to influence the 
risk of infection. A 20-fold increased risk of infection with metal hinged prosthetic knee 
joints compared to metal-to-plastic prostheses has been reported (Poss, et al. 1984).  
A number of postoperative risk factors for prosthetic joint infection have also been 
identified. The most important of these appears to be postoperative wound complications 
including the presence of superficial infection and/or wound discharge (Bengtson & 
Knutson 1991, Surin, et al. 1983, Wymenga, et al. 1992). Superficial infection, occurs within 
30 days of the operative procedure, only involves the superficial structures and additionally 
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includes one of the following features: purulent discharge, isolation of micro-organisms 
through aseptic sampling techniques or clinical features of infection (Horan, et al. 1992). 
Applying this definition, patients with a postoperative surgical site infection had around a 
36 fold increase in the risk of the subsequent development of a deep prosthetic wound in 
one study(Berbari, et al. 1998). Similarly, in another study examining patients with deep 
prosthetic infections acquired in the perioperative period, 25 of the 26 patients described 
preceding wound complications, which included; the persistent drainage of fluid from the 
wound, development of a haematoma under the wound, a superficial infection or a stitch 
abscesses (Poss, et al. 1984). Of note we have demonstrated that the use of closed suction 
drainage in total knee arthroplasty is protective of prosthetic knee infection and this may be 
due the role of a drainage tube in minimizing haematoma formation (Dowsey & Choong 
2009). Early post-operative persistent discharge of fluid from the wound has been associated 
with a 3.2 times higher risk of deep prosthetic joint infection. Often in these cases the same 
pathogenic organisms isolated from the discharging fluid is later recovered at time of 
reoperation on the infected hip (Surin, et al. 1983). 
Postoperative medical complications including atrial fibrillation and myocardial infarction 
have also been implicated as risk factors for deep prosthetic joint infection, with a 6-fold and 
20-fold respective increase reported (Pulido, et al. 2008). One postulated mechanism to 
account for this association is that standard management of these medical conditions 
includes anticoagulation. In the postoperative period this may increase the risk of bleeding 
and haematoma formation near the wound, which in itself may increase the risk of infection. 
Secondly, these medical complications may necessitate longer inpatient hospital stay, which 
may be associated with nosocomial acquisition of infection. Allogenic blood transfusion was 
also identified as conferring a twofold increased risk of prosthetic infection, again the risk 
may be via an association with bleeding and haematoma formation near the wound, or 
possibly as a marker of complications and prolonged hospitalisation (Pulido, et al. 2008). 
Nosocomial infections, particularly urinary tract infections have also been identified as risk 
factors for deep prosthetic joint infections. Surin et al demonstrated that patients with 
remote infections in the postoperative period were three times more likely to develop deep 
infections. Over three quarters of these infections were urinary tract infections. Interestingly 
however, there was no correlation between causative agents of the nosocomial infection and 
the micro-organism ultimately isolated from the infected prosthesis (Surin, et al. 1983). 
These results have been confirmed by other studies (Pulido, et al. 2008, Wilson, et al. 1990). 
Bengston et al highlighted the significance of skin infections in haematogenous seeding of 
the prosthesis. One third of patients with haematogenous seeding in this cohort had 
concurrent or preceding skin infections that were identified as the probable primary focus 
for the bacteraemia(Bengtson & Knutson 1991).  
2.3 Microbiology 
Staphylococcus species account for approximately half of all prosthetic joint infections; this 
includes Staphylococcus aureus and coagulase negative Staphylococcus species, both 
methicillin sensitive and resistant. Gram-negative bacilli infections and polymicrobial 
infections are the two next most common groups of pathogens described. Other gram-
positive bacteria such as Streptococcus and Enterococcus species occur less commonly 
(Bengtson & Knutson 1991, Berbari, et al. 1998, Fitzgerald, et al. 1977, Moran, et al. 2007, 
Pandey, et al. 2000, Pulido, et al. 2008, Steckelberg & Osmon 2000). Importantly, in all series, 
www.intechopen.com
 
Recent Advances in Arthroplasty 
 
416 
a small number of cases meet the definition for prosthetic joint infection, and yet remain 
culture negative on standard microbiologic techniques. 
 
Reference 1 2 3 4 5 6 7 8 9  
Total number of 
isolates 
112 248 81 578 63 462 357 42 112  
Coagulase negative 
Staphylococcus 
13 31 48 30 21 19 17 24 33 27.3 
Staphylococcus aureus 23 21 14 23 38 22 42 19 17 23.8 
Streptococcus spp 5 7 10 9 13 9 6 12 10.7 9.4 
Enterococcus spp 3 6 7 3 0 1 3 10 6.3 4.6 
Diptheroids 2 4 4 0.5 2 0.6 1 0 5.4 2.6 
Gram-negative bacilli 6 28 0 6 11 8 5 29 16.1 12.7 
Propionibacterium 0 0.4 3 1.5 0 0 0.3 2 0.9 0.9 
Polymicrobial 33 0 12 12 6 19 15 0 0 9.7 
Anaerobes 3 2 0 2 0 6 2 2 6.3 3.0 
Other 1 4 0 2 0 3 0.3 19 2.7 3.5 
Culture negative 5 0 0 11 10 12 8 2 1.8 5.2 
1. (Moran, et al. 2007), 2. (Sharma, et al. 2008), 3. (Pandey, et al. 2000), 4. (Steckelberg & Osmon 2000), 5. 
(Pulido, et al. 2008), 6. (Berbari, et al. 1998), 7. (Bengtson & Knutson 1991), 8. (Fitzgerald, et al. 1977), 9. 
(McDonald, et al. 1989) 
Table 1. Microbiological isolates in reported literature (percent) 
3. Pathogenesis 
3.1 Acquisition of infection 
Acquisition of prosthetic joint infection occurs by two mechanisms: direct inoculation and 
haematogenous seeding. Direct inoculation of the prosthesis may occur at the time of 
implantation or with manipulation of the arthroplasty and is thought to be the predominant 
mechanism of infection. In a study by Southwood et al the 50% infective dose (ID50) of 
Staphylococcus aureus required to induce infection with direct inoculation of the prosthesis 
was just 50 organisms. This compared to an intravenous inoculum dose of 100 000 
organisms at the time of operation for bacteraemic seeding and infection of the prosthesis to 
occur. Southwood also demonstrated that three weeks after implantation of the prosthesis, 
the likelihood of bacteraemic seeding of the prosthesis was significantly reduced. In fact, in 
the rabbit model, the inoculum of intravenous bacteria required was near to the lethal 
dose(Southwood, et al. 1985). Nevertheless, haematogenous seeding remains an important 
cause of arthroplasty infections and it has been reported that up to 34% of patients with 
prosthetic joints in-situ developed deep infection of that prosthesis following an intercurrent 
episode of Staphylococcus aureus bacteraemia (Murdoch, et al. 2001).  
Whilst theoretically distinct, clinically there is significant overlap between both mechanisms 
of infection. The simplified view is that infection resulting from inoculation occurs within 
the first year of implantation whilst haematogenous infections occur later. However the 
clinical presentation of prosthetic joint infections acquired during the original operation 
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may be much more delayed, particularly with low virulence organisms such as coagulase 
negative staphylococcus species (Steckelberg & Osmon 2000). Furthermore, up to 50% of 
suspected prosthetic joint infections of haematogenous origin present within the first two 
years (Deacon, et al. 1996). However it is important to note that distinguishing between 
whether an episode of bacteraemia led to haematogenous seeding of a prosthetic joint or 
whether the primary source of the bacteraemia was a subclinical prosthetic joint infection 
can be problematic.  
3.2 The role of biofilms 
The pathogenesis of prosthetic joint infections is intimately connected to the property of 
biofilm formation by microorganisms. The presence of this biofilm can have a critical effect 
on the likely success of treatment for a number of reasons. Bacteria can exist in two unique 
forms; the free living or planktonic forms characterised by rapid cellular division, and the 
stationary or sessile forms characterised by slower cellular division (Costerton 1999, 
Costerton, et al. 1995). 
The sessile bacteria secrete an extracellular matrix or slime. Together the microorganisms 
and this matrix comprise what is known as ‘the biofilm’. The abiotic matrix performs a 
number of functions including provision of anchorage onto structures to support the sessile 
colonies(Donlan & Costerton 2002). It also facilitates communication between bacteria 
within the biofilm. This communication termed ‘quorum sensing’, is analogous to the 
paracrine signalling in multicellular organisms and enables the bacteria to regulate their 
gene synthesis(Gristina & Costerton 2009). Importantly, the matrix can provide bacteria 
with protection from antimicrobial chemicals and from host defense mechanisms. This 
impairment of host defense mechanisms has been demonstrated in a number of in vitro 
models. For example, the extracellular slime produced by Staphylococcus epidermidis can 
inhibit the phagocytic activity of neutrophils(Shiau & Wu 1998).  
The concentration of antibiotic required to inhibit the growth of bacteria in biofilms is higher 
than that required to kill free-living bacteria. The mean inhibitory concentration (MIC) of 
many antibiotics is higher with the sessile forms than corresponding planktonic forms. 
Studies have demonstrated up to a 1000 fold increase in the MIC to particular antibiotics for 
bacteria moving from the planktonic to the sessile phenotype (Amorena, et al. 1999, Jones, et 
al. 2001, Rose & Poppens 2009, Schwank, et al. 1998, Souli & Giamarellou 1998, Stewart & 
Costerton 2001). This poses a major challenge for clinicians interpreting the reported 
antibiotic susceptibility results of bacteria, as our standard laboratory antibiotic 
susceptibility testing uses only the planktonic forms of bacteria. Newer technologies 
including the Calgary Biofilm Device can enable antibiotic susceptibility testing of the sessile 
phenotype of bacteria, but at present these are limited to a research setting and are not 
widely available(Ceri, et al. 1999).  
There are a number of postulated mechanisms for the apparent resistance of biofilm residing 
bacteria to the effects of antibiotics. Firstly, the antibiotic may be deactivated at the surface 
of the biofilm. Secondly, the altered nutritional and biochemical environment within the 
biofilm may alter the activity of the antibiotics. Thirdly, antibiotics, particular cell wall active 
antibiotics such as betalactam antibiotics, rely on rapid growth and reproduction of the 
microorganism for their effect. These antibiotics are effective against the planktonic 
phenotype but have limited efficacy against the sessile phenotype as cellular turnover is 
greatly reduced. Finally the sessile forms act as ‘spore-like’ structures, which may act as a 
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nidus for later relapse of infection (Costerton 1999, Stewart & Costerton 2001, Trampuz, et 
al. 2003, Zimmerli 2006).  
The properties of the biofilm alter with time; with age many biofilms become increasingly 
resistant to antibiotics. Monzon et al demonstrated the efficacy of vancomycin against 
Staphylococcus epidermidis decreased as a biofilm aged. This phenomenon was not consistent 
with all antibiotics; the activity of rifampicin and tetracyclines was not altered (Monzon, et 
al. 2002). Using Ribosomal RNA Fluorescence In Situ Hybridization studies, Poulson et al 
assessed the growth rate of biofilms and demonstrated that the cellular turnover was 
significantly higher in younger biofilms compared to established biofilms (Poulsen, et al. 
1993). This finding could account for the difference to antimicrobial susceptibility observed. 
Implant factors are also recognised to play a role in the pathogenesis of infection. 
Biochemical properties of prosthetic material influences bacterial adhesion and may impair 
host immune responses. For example, methyl methacrylate cement has been shown to 
inhibit complement and lymphocyte activity (Panush & Petty 1978, Petty 1978).  
4. Diagnosis 
4.1 Clinical features 
The clinical diagnosis of prosthetic joints is challenging. Many typical symptoms of 
infection are often absent. Pain is the predominant symptom of prosthetic joint infections 
and is present in 90 to 100% of patients. The presence of fever is variable with 9 to 43% of 
patients in most case series having documented elevated temperatures (Canner, et al. 
1984, Inman, et al. 1984, McDonald, et al. 1989, Miley, et al. 1982, Morrey, et al. 1989, 
Windsor, et al. 1990). In acute infections, erythema and swelling of the joint are often 
present, but are less common in more chronic infections (Del Pozo & Patel 2009, Miley, et 
al. 1982, Zimmerli, et al. 2004). A discharging sinus is associated with chronic, indolent 
presentations (Del Pozo & Patel 2009). 
Zimmerli et al classifies arthroplasty infections as: Early (developing in the first three 
months after surgery), Delayed (occurring three to 24 months after surgery) and Late 
(greater than 24 months). This classification roughly correlates to important observed 
differences in the causative pathogens; with virulent organisms such as Staphylococcus aureus 
characteristically presenting earlier and more indolent pathogens such as coagulase negative 
Staphylococcus usually presenting later (Zimmerli, et al. 2004).  
4.2 Laboratory studies 
Peripheral blood leucocytosis is a poor predictor of infected arthroplasty; less than 10% of 
patients with an infected prosthesis have an elevated white cell count in most series 
(Canner, et al. 1984, Inman, et al. 1984, Zimmerli, et al. 2004). Other biochemical tests, 
such as the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are more 
useful diagnostic tests for these infections. For patients with proven infection of knee or 
hip arthroplasty, the ESR had a sensitivity of 81-92% and a specificity of 90-96%, while the 
CRP had a sensitivity of 84-89% and a specificity of 83-96% (Bottner, et al. 2007, Spangehl, 
et al. 1999). There are however, limitations to the diagnostic utility of the ESR and CRP. 
These markers are normally elevated after primary uncomplicated arthroplasty; the ESR 
peaks in the first week and may remain elevated for up to a year, while the CRP peaks at 
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day 2 and may remain elevated for 3 weeks (Aalto, et al. 1984, Larsson, et al. 1992, Shih, et 
al. 1987).  
The search for other biochemical markers of infection has included interleukin 6 (Il-6), 
tumour necrosis factor α (TNF-α) and procalcitonin C. Il-6 and TNF-α are cytokines 
released by monocytes and macrophages in the setting of infection (Bottner, et al. 2007). 
Procalcitonin is a precursor of calcitonin, and has been shown to be a specific marker of 
bacterial sepsis (Fernandez Lopez, et al. 2003). In a review by Bottner et al of 78 patients 
undergoing revision arthroplasties Il-6, TNF-α and procalcitonin were all significantly 
elevated in patients with confirmed septic loosening. The sensitivity and specificity 
respectively of Il-6 was 95% and 87%, TNF-α 43% and 94% and procalcitonin 33% and 
98%. (Bottner, et al. 2007). Il-6 is elevated in the post-operative period for primary 
arthroplasty however, in a study by Shah et al, Il-6 was shown to return to normal levels 
within 2 days of the operation. Therefore there is potential diagnostic utility of Il-6 over 
CRP and ESR in the early post-operative period if infection is suspected, particularly in 
the first 21 days (Shah, et al. 2009).  
Synovial fluid characteristics can be used to assist in diagnosis of prosthetic joint infections. 
In a study by Trampuz and colleagues, the leucocyte count was significantly higher in 
patients with prosthetic joint infection with a median of 18.9 x 103/µL (range, 0.3 to 178 x 
103/µL) compared to a median leucocyte count of 0.3 x 103/µL (range, 0.1 to 16 x 103/µL) in 
patients with aseptic loosening. Using receiver operating characteristic (ROC) curves the 
authors found a synovial total white cell count 1.7 x 103/µL and a leucocyte differential of 
greater than 65% neutrophils had a sensitivity and specificity of 94%, 88% and 97%, 98% 
respectively (Trampuz, et al. 2004). 
4.3 Radiological studies 
Plain radiographs lack sensitivity and specificity in diagnosing septic arthroplasty. Findings 
such as lucency around the prosthesis can be noted in both septic and aseptic loosening 
situations (Figure 1 A-D). In early infection plain radiographs are frequently normal (Miller 
2005). 
Technetium-Methylene Diphosphonate (MDP) bone scintigraphy is a sensitive test for 
prosthetic joint infection (Figure 1 E-G), but lacks specificity, as it does not differentiate 
between aseptic and septic loosening(Ghanem, et al. 2009). The bone scan can also remain 
positive for a year following primary arthroplasty. Bone scan does have a high negative 
predictive value therefore bone scans potentially can be used to exclude infection in the 
setting of a painful prosthetic joint (Smith, et al. 2001). Similar findings have been 
documented with newer modalities such as 18F-Fluoro-deoxyglucose positron emission 
tomography (FDG-PET) (Delank, et al. 2006, Zoccali, et al. 2009). A recent meta-analysis of 
FDG-PET reported a sensitivity of 82.1% and specificity of 86.6% for the presence of 
prosthetic joint infection, and hence this may be a useful test if available(Kwee, et al. 
2008).  
Computer tomography (CT) and magnetic resonance imaging are not considered useful 
imaging modalities due to artefact from the metal prosthesis interfering with interpretation 
of imaging findings. However newer CT scanners can minimise this effect and may be 
useful in detecting abnormalities of the soft tissues in periprosthetic infections (Figure 2 A-
E) but do not diagnose periprosthetic bone abnormalities well (Cyteval, et al. 2002)  
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Fig. 1. (A) Painful (left) cementless hip prosthesis in situ. (B) Note extrinsic scalloping of 
anterior cortex of femoral diaphysis (box). (C) Magnified image of anterior femoral cortex 
with extrinsic scalloping (arrows) caused by soft tissue abscess (D). (E) Nuclear bone scan 
(TcMDP) demonstrating mild uptake over left proximal femur. Indium white cell scan at (F) 
4 hours and (G) showing marked retention of nuclear tracer at 20 hours. 
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Fig. 2. (A) Localised infective sinus at the centre of incision used for total knee joint 
replacement. (B) plain radiograph showing periprosthetic sclerosis and lysis under the tibial 
component. (C) Magnified image showing obvious periprosthetic lysis (arrows). (D) 
Computer tomogram showing lysis under tibial component extending through medial 
cortex as cloaca (arrow). (E) Computer tomogram demonstrating soft tissue abscess 
formation (arrows) in continuity with intramedullary suppuration. 
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4.4 Histopathology diagnosis 
Intraoperative frozen section histopathologic studies of periprosthetic tissue can be used as 
an adjunctive test for the diagnosis of prosthetic joint infections. An early paper showed a 
correlation between the polymorphonuclear leucocyte (PMN) count in tissue on 
histopathologic examination and the diagnosis of infection (Mirra, et al. 1976). Subsequent 
studies using  frozen section histopathology for revision arthroplasty (using a PMN count of 
five to ten cells per high power field to diagnose infection) had a sensitivity of 50-93% and 
sensitivity of 77-100% (Bori, et al. 2006, Frances Borrego, et al. 2007, Ko, et al. 2005, Nunez, et 
al. 2007). It should be noted that inflammatory conditions such as rheumatoid arthritis may 
also cause a high PMN count, hence lowering specificity (Mirra, et al. 1976). 
4.5 Microbiology diagnosis 
The identification of the causative pathogen in a prosthetic device infection is of paramount 
importance. It allows for the institution of appropriate management strategies for infection 
including selection of the most appropriate antibiotic to target the pathogen, while 
minimising unnecessary antibiotic overuse, thus decreasing the incidence of drug toxicity 
and generally permitting simpler drug regimens to improve patient adherence.  
It has earlier been noted that culture negative prosthetic joint infections continue to occur. 
Recent studies have focused on methods to increase the sensitivity of microbiological 
diagnostic techniques to address this problem. In a prospective study, which aimed to 
establish microbiological criteria for the diagnosis of prosthetic joint infection in revision 
arthroplasty, Atkins et al found that the isolation of indistinguishable microorganisms from 
three or more periprosthetic tissue samples has a sensitivity of 65% and a specificity of 
99.6% for prosthetic joint infection. Utilising mathematical modelling the authors 
recommended that five to six intraoperative specimens of periprosthetic tissue be obtained 
to optimise the likelihood of a microbiologic diagnosis in prosthetic joint infection. They also 
noted that routine gram staining of periprosthetic tissue at revision arthroplasty had a very 
low sensitivity (12%) and the authors recommended that gram stain should be abandoned in 
revision arthroplasty cases, instead relying on culture (Atkins, et al. 1998). 
Prolonged cultures may also help to improve the diagnostic yield. An increase in positive 
culture results of 24.6% when culture incubation of periprosthetic tissue samples was 
increased from 3 to fourteen days has been reported and in particular the isolation of 
fastidious organisms, such as Propionibacterium species was increased (Schafer, et al. 2008).  
A number of techniques have been developed in an attempt to disrupt the biofilm and 
increase the yield of microbiological cultures. One such technique is ultrasonification 
whereby the explanted prosthesis is placed in a sterile polyethylene bag then in a sterile 
anaerobic jar, Ringer’s solution is added and sonification is performed. The sonicate fluid is 
cultured aerobically and anaerobically. One study comparing sonification to standard tissue 
culture involving 331 patients of whom 79 had prosthetic joint infections; sonification 
yielded an additional 14 microbiological diagnosis with a reported sensitivity of 78.5% and 
specificity of 98.8%. The authors noted that sonification was particularly useful in cases 
where patients had received antibiotics perioperatively (Trampuz, et al. 2007).  
4.6 Molecular techniques 
Newer molecular techniques have been applied to prosthetic joint infections to increase 
the diagnostic yield including polymerase chain reaction (PCR), fluorescent in situ 
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hybridization (FISH) and immunofluorescent microscopy (IFM). Both PCR and FISH 
target specific regions of bacterial genetic material, commonly bacterial ribosomal RNA 
(rRNA). The advantage of using rRNA is that it is highly conserved in bacterial species 
compared to most protein encoding genes. Both methods can use broad range 
oligonucleotide primers or more targeted primers including genus and species specific 
primers (Amann & Fuchs 2008).  
A number of studies investigating the role of bacterial 16s rRNA PCR have been performed. 
Sensitivities of this technique ranged from 63-100% in detecting bacteria involved in 
prosthetic joint infection (De Man, et al. 2009, Hoeffel, et al. 1999, Mariani, et al. 1996, 
Moojen, et al. 2007). In a study by Mariani et al 50 patients with symptoms following total 
knee arthroplasty underwent synovial fluid and intraoperative tissue sampling for culture 
and PCR; cultures were positive in fifteen specimens compared to 32 specimens when PCR 
was applied (Mariani, et al. 1996). Likewise Tunney et al used PCR in a study of 120 patients 
undergoing prosthetic hip joint revision. The explanted prosthesis underwent 
ultrasonification and this fluid was cultured and underwent 16s DNA PCR. Standard 
microbiologic cultures were positive in 22% of patients, compared to 72% of patients with 
positive results from PCR (Tunney, et al. 1999). The limitation of these studies was a paucity 
of correlation with clinical or histological features of infection. In a review of 34 patients 
with confirmed prosthetic joint infection Vandercam et al found that PCR was positive in 31 
of 34 patients (91.2%), compared to positive microbiological culture in 22 of 34 patients 
(64.7%). Of import, eight of the nine patients with positive PCR but negative culture results 
had received antibiotic therapy in the prior ten days (Vandercam, et al. 2008). Despite these 
promising results, the weakness of 16s ribosomal RNA PCR techniques is the low specificity 
and high false positive rate. In a study by Clarke et al 29% of the patients without septic 
arthritis (on the basis of clinical, radiological, biochemical, intraoperative findings, culture 
and histology) had positive PCR results, this was particularly pronounced in the cohort 
undergoing revision arthroplasty for aseptic loosening where 46% of patients had positive 
PCR (Clarke, et al. 2004). The high false positive rate may be due to a number of factors 
including contamination of specimen or the reagents and detection of necrotic bacterial 
DNA (Bauer, et al. 2006). Importantly though, many patients labelled as having aseptic 
loosening may in fact have had low grade chronic infection contributing to prosthesis 
loosening. Given that there is no gold standard to define prosthetic joint infection, the 
specificity of PCR remains difficult to judge. 
FISH is a technique that uses labelled oligonucleotide probes that hybridise to specific 
genetic regions on bacteria and are subsequently visualised using fluorescent microscopy or 
flow cytometry (Amann & Fuchs 2008, Moter & Gobel 2000). Probes to detect bacterial 
rRNA or other genetic targets are available and these include species specific probes, 
therefore allowing identification and simultaneous observation of the different bacteria. 
FISH also allows an appreciation of the architectural arrangement of the organisms within 
the biofilm which can assist in differentiating true infections from contamination (McDowell 
& Patrick 2005, Moter & Gobel 2000). In orthopaedic infections it has been demonstrated 
that Staphylococcus aureus and Staphylococcus epidermidis could be visualised and 
differentiated in an experimental biofilm. Additionally, in a clinical case of septic loosening 
of a hip prosthesis, Staphylococcus epidermidis was visualised using FISH techniques in 
periprosthetic tissue samples(Krimmer, et al. 1999). FISH has otherwise not yet been widely 
applied to prosthetic joint infections in a clinical setting. 
www.intechopen.com
 
Recent Advances in Arthroplasty 
 
424 
Immunofluorescence microscopy (IFM) is another novel nonculture technique for 
diagnosing prosthetic joint infections. In immunofluorescence microscopy, samples are 
mixed with monoclonal antibodies (MAb) to specific antigens on bacterial cell walls. 
Samples are then incubated with a second antibody conjugated with a fluorescent dye. The 
bacteria are then visualised using fluorescence microscopy(Tunney, et al. 1999). As with 
FISH, IFM can be used to assess the biofilm structure and can detect multiple pathogens 
(McDowell & Patrick 2005, Tunney, et al. 1999). In the study by Tunney et al IFM was 
performed on the sonicate fluid from explanted prostheses using Mab for both 
Propionibacterium and Staphylococcus species. (Tunney, et al. 1999).  
5. Treatment 
5.1 Treatment goal 
Optimal treatment of prosthetic joint infections involves the eradication of infection whilst 
maintaining function of the joint and patient quality of life (Zimmerli, et al. 2004). However 
there are no large, multi-centred, randomised prospective studies of treatment strategies to 
guide recommendations. The successful treatment of prosthetic joints is contingent on the 
elimination of the biofilm dwelling microorganism. The two mainstay methods of achieving 
this are through either surgical removal of the prosthesis or through use of biofilm active 
antibiotics in conjunction with surgical debridement and retention of the prosthesis. 
The surgical strategies used to treat arthroplasty infections include: resection arthroplasty, 
one-stage or two-stage exchange procedures, amputation and debridement and retention. 
Resection arthroplasty entails the removal of all foreign material including cement, resection 
of devitalised tissue and bone and may or may not involve arthrodesis. Exchange 
procedures involve resection arthroplasty with reimplantation of a new joint prosthesis 
performed at the time of removal of the infected prosthesis (one-stage exchange); or delayed 
by a variable period of time while antibiotic therapy is administered (two-stage exchange). 
Debridement and retention of the prosthesis usually involves open arthrotomy, removal of 
all infected and necrotic bone, exchange of liners and lavage of the joint (Giulieri, et al. 2004, 
Matthews, et al. 2009, Rand, et al. 1986, Steckelberg & Osmon 2000, Trampuz & Zimmerli 
2008, Zimmerli, et al. 2004). 
A number of factors influence the surgical approach selected for an individual patient, these 
include a patient’s general health and fitness for anaesthesia, condition of the prosthesis and 
bone stock, the causative agent, the timing of the infection relative to the prosthesis 
insertion, the availability of effective antibiotics and clinicians’ and patient preference.  
5.2 Systemic antibiotic therapy without surgical debridement 
Administration of antibiotic therapy without surgical management is not routinely 
recommended, as it is rarely associated with successful cure. Early studies of antibiotic 
therapy alone for prosthetic joint infections had disappointing results with successful 
outcomes in as little as  8-15% of patients (Bengtson, et al. 1989, Canner, et al. 1984). The 
confounding factor when analysing these poor results is that biofilm active antibiotics, were 
not used. Treatment with biofilm active antibiotics alone including rifampicin and 
ciprofloxacin for three to six months has yielded successful outcomes in highly selected 
patients; those presenting with early infections (less than one year following implant), 
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infection due to Staphylococcus aureus, absence of implant loosening and strict adherence to 
treatment (Trebse, et al. 2005). However, antibiotic suppression alone is generally reserved 
for patients with significant comorbidities in whom surgery is contraindicated, who are 
without evidence of systemic infection and where tolerable oral antibiotics are available. 
Given the low likelihood of cure, many clinicians view this as long term, often lifelong 
suppressive therapy, embarked upon without curative intent (Steckelberg & Osmon 2000, 
Zimmerli, et al. 2004). 
5.3 Exchange arthroplasty  
Interpretation of the current literature describing the outcomes of patients having one- and 
two-stage exchange procedures is challenging owing to the heterogeneity of the patient 
populations, the causative organisms and the surgical techniques (including use of antibiotic 
impregnated cement), the differences in the duration of patient follow up and probable 
publication bias. The greatest concern with one-stage exchange procedures is the 
implantation of the prosthesis into an infected field with subsequent reinfection of the 
revised arthroplasty. In one-stage exchange, reported success rates range from 38-100%; but 
there is significant variability in the definition of success which includes freedom from 
infection, freedom from pain or simply the presence of a functional joint (Callaghan, et al. 
1999, Jamsen, et al. 2009, Steckelberg & Osman 2000). In examination of the outcomes of one-
stage exchange revision hip arthroplasty, 80% (range 57-92%) of patients have been reported 
to remain infection free after one-stage exchange without the use of antibiotic cement 
(Steckelberg & Osman 2000). When antibiotic impregnated cement was used, 88% (range 76-
100%) of patients have been reported to remain infection free at follow up (Callaghan, et al. 
1999, Jackson & Schmalzried 2000, Langlais 2003, Steckelberg & Osman 2000). Results for 
one-stage exchange in knee arthroplasty revision are in general worse than for hips, with 
only 65% (range 57-100%) of patients remaining free of recurrence of infection at follow up 
(Steckelberg & Osmon 2000). On the basis of these results, one-stage exchange of an infected 
prosthesis is rarely advised for prosthetic knee infections(Trampuz & Zimmerli 2008, 
Zimmerli, et al. 2004). There are, however some advantages with one-stage exchange; 
patients undergo a single operation and generally require a shorter period of hospitalisation 
in total.  
Consensus recommendations for one-stage exchange suggest that it should only be 
considered where there is minimal soft tissue damage and where less virulent organisms 
are involved (Hirakawa, et al. 1998, Jackson & Schmalzried 2000, Miley, et al. 1982, 
Trampuz & Zimmerli 2008, Zimmerli, et al. 2004). The presence of sinus tract is 
considered a relative contraindication for one-stage exchange. Ideally the causative agent 
should be known prior to resection arthroplasty and treatment commenced 
preoperatively(Zimmerli, et al. 2004).  
In two-stage exchange procedures, reimplantation is delayed for a variable length of time 
from 2 weeks to several months. Spacers impregnated with antibiotic are commonly 
inserted to maintain limb length and improve patient mobility during that interval (Leunig, 
et al. 1998). Antibiotics with activity against the isolated pathogen are administered for at 
least 6 weeks. Tissue samples are often routinely taken from the periprosthetic tissue at the 
time of reimplantation for microbiological culture to assess the efficacy of the interim 
treatment (Insall, et al. 1983, Wilson, et al. 1990, Windsor, et al. 1990). In infections with 
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difficult-to-treat micro-organisms such as MRSA, resistant enterococci and fungi, current 
consensus guidelines recommends prolonged interval between removal and reimplantation 
without the use of a spacer (Trampuz & Zimmerli 2008, Zimmerli, et al. 2004)  
Two-stage exchange, in general, has a higher success rate compared to one-stage with rates 
of 63-100% (Colyer & Capello 1994, Haleem, et al. 2004, Jamsen, et al. 2009, Woods, et al. 
1983). In hip arthroplasty two-stage exchange without the use of antibiotic impregnated 
cement, 81% of patients (range 53-100%) remain free of recurrent infection increasing to 93% 
(73-100%) when antibiotic cement is used (Laffer, et al. 2006, Langlais, et al. 2006, 
Steckelberg & Osman 2000). In knee arthroplasty infections, 84% (38-100%) of patients in 
whom antibiotic cement is not used, and 88% (63-100%) of patients in whom antibiotic 
impregnated cement is used remain infection free following two stage exchange (Bengtson, 
et al. 1989, Grogan, et al. 1986, Hanssen, et al. 1994, Insall, et al. 1983, Morrey, et al. 1989, 
Rand, et al. 1986, Wang & Chen 1997, Wasielewski, et al. 1996, Wilson, et al. 1990, Windsor, 
et al. 1990, Woods, et al. 1983). 
A number of factors potentially influence treatment outcomes in two-stage exchange 
procedures. Polymicrobial infection, infection with virulent organisms including 
Staphylococcus aureus and methicillin resistant coagulase negative Staphylococcus species, 
the presence of rheumatoid arthritis and a history of prior multiple revisions have all been 
shown to associated with lower rates of success in two-stage exchanges (Hirakawa, et al. 
1998, Lim, et al. 2009, Mittal, et al. 2007). Current consensus guidelines recommend two-
stage exchange in chronic infections with moderately or severely damaged tissue or if a 
sinus tract is present (Trampuz & Zimmerli 2008, Zimmerli, et al. 2004).  
5.4 Resection arthroplasty  
Resection arthroplasty and amputation are generally reserved for patients with refractory 
infections particularly where there is severe loss of bone stock or where functional 
improvement following revision is unlikely (Trampuz & Zimmerli 2008, Zimmerli, et al. 
2004). Whilst rates of recurrence of infection are low, patients have worse functional 
outcomes and up to 80% of patients report residual pain following resection  (Morrey, et al. 
1989). 
5.5 Debridement and retention of the prosthesis 
Debridement and retention of the prosthesis is an attractive treatment option for many 
patients given that it is the least invasive, with a lower surgical morbidity, and is 
generally associated with good functional outcomes (Trampuz & Zimmerli 2008, 
Zimmerli, et al. 2004). Open arthrotomy and debridement is recommended when 
attempting retention of the prosthesis as poorer results are reported with arthroscopic 
‘washout’ compared to open ‘washout’(Laffer, et al. 2006). Following debridement, 
patients should receive biofilm active antibiotics generally for a longer duration than with 
surgical exchange or resection.  
Early studies of debridement and prosthesis retention strategies to treat prosthetic joint 
infection were disappointing with recurrence of infection at 2 years reported in 69% of 
patients (Brandt, et al. 1997). Poor outcomes have been reported when symptoms are 
present greater than 8 days, when a sinus tract is present and with late chronic infections; In 
some instances all patients with late infection experienced treatment failure (Berbari, et al. 
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2006a, Crockarell, et al. 1998, Marculescu, et al. 2006b). High failure rates have also observed 
with specific organisms, only 12% of patients with Staphylococcus aureus infection 
experiencing successful treatment outcomes (Deirmengian, et al. 2003, Marculescu, et al. 
2006a). Gram-negative infections, polymicrobial infections and culture negative prosthetic 
joint infections were also associated with higher rates of recurrence of infection following 
debridement and retention (Berbari, et al. 2007, Hsieh, et al. 2009a, Marculescu & Cantey 
2008). However, successful outcomes have been reported in the setting of early or 
haematogenous infections (Morrey, et al. 1989, Wasielewski, et al. 1996). Tsuyakama et al 
reported a successful outcome in 71% of patients with early infections treated with 
debridement of the prosthetic joint followed by four weeks of parenteral antibiotics with an 
average follow up of 3.8 years (Tsukayama, et al. 1996).  
Newer treatment strategies evolved as understanding of the role of biofilm in the 
pathogenesis of prosthetic joint infections increased. In vivo studies using guinea pig 
tissue-cage animal model by Widmer et al demonstrated the clinical utility of rifampicin 
in chronic biofilm infections (Widmer, et al. 1990). Further studies also identified that 
quinolones retained activity in the presence of biofilms (Schwank, et al. 1998, Widmer, et 
al. 1991).  
The addition of rifampicin to antimicrobial regimens has led to a significant improvement 
in success rates reported in the treatment of gram-positive prosthetic joint infection; in 
many instances comparable to that reported for two-stage exchange. In our experience 
combination treatment including rifampicin has resulted in successful treatment in up to 
90% of patients (Aboltins, et al. 2007); however successful outcomes are associated with 
several factors. Higher success rates are reported where the causative organism is a 
staphylococcus species and when antibiotic therapy is continued for a protracted period; 
12 months or greater, (Choong, et al. 2007, Widmer, et al. 1992). In contrast the rate of 
success is significantly diminished when a fistula is present, particularly in knee 
arthroplasty where successful outcomes have been reported in only 45-69% of patients. 
(Drancourt, et al. 1993).  
The only randomised double-blinded control trial examining the role of rifampicin in the 
treatment of prosthetic device staphylococcal infections was conducted from 1992 through 
1997. The study involved 33 patients with orthopaedic device infections and duration of 
symptoms less than one year. Patients were randomised to receive rifampicin 450mg and 
ciprofloxacin 750mg (twice daily) or ciprofloxacin and placebo. Rifampicin/ciprofloxacin 
combination was successful in all patients compared to 58% of patients who received 
ciprofloxacin alone (Zimmerli, et al. 1998). Subsequent studies corroborated these results 
with success rates of greater than 85% of patients treated with debridement and retention 
and rifampicin containing antibiotic treatment (Berdal, et al. 2005, Byren, et al. 2009, Rao, et 
al. 2003). The main limitations with the use of rifampicin are the high likelihood of 
generation of resistance when used without a second antibiotic and the hepatic and 
gastrointestinal toxicities (John, et al. 2009, Widmer, et al. 1990). Therefore careful, regular 
follow up of patients is necessary and the management these antibiotics should involve 
collaboration between Infectious Diseases Physicians and Orthopaedic Surgeons.  
The investigation of newer agents for the treatment of prosthetic joint infection is ongoing. 
In guinea pig foreign-body infection model, John et al assessed the activity of newer agents 
including linezolid and daptomycin, alone and in combination with rifampicin. In this study 
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neither daptomycin nor linezolid had activity against adherent MRSA when used as 
monotherapy. When used in combination with rifampicin, daptomycin at a dose of 
30mg/kg (corresponding to a dose of 6mg/kg in humans) cured 67% of cage infections. At 
this dose, no cases of rifampicin resistance emerged. Results were less encouraging for 
linezolid; even in combination with rifampicin, linezolid failed to cure any cage infection. 
Resistance to rifampicin emerged in 8% of cage infections treated with rifampicin-linezolid 
combinations (John, et al. 2009).  
For gram-negative infections, ciprofloxacin has been shown to be effective in guinea pig 
tissue cage models(Widmer, et al. 1991). In a study of 28 patients with bone and joint 
infections secondary to gram-negative bacilli combination therapy with cefepime and 
fluoroquinolone obtained a cure in 79% of patients. However only 5 patients in this cohort 
had a prosthetic joint infection, two were treated with debridement and retention and 
only one of which was cured (the second patient died from a cause unrelated to the 
infection)(Legout, et al. 2006). In prosthetic joint infection secondary to gram negative 
bacilli, debridement and retention has yielded a success rate as low as 27% (Hsieh, et al. 
2009b). This contrasts with our results where by infection free survival at 2 years was 94% 
in gram-negative infections when fluoroquinolone was used in conjunction with 
debridement and retention (Aboltins, et al. 2011). Again this is in the setting of short 
duration of symptoms (median 7 days) and prolonged oral antibiotic treatment (median 
12 months).  
The duration of antibiotic after debridement and retention varies in reported clinical studies 
ranging from six months to greater than 4 years. In a study by Laffer et al there was no 
difference in outcome in patients receiving three to six months of antibiotics compared with 
greater than six months (91% v 87% success). In this study patients were followed up for a 
median duration of 28 (range, 2–193) months and 55% of infections were caused by 
Staphylococcus species(Laffer, et al. 2006). In accordance with consensus guidelines, 
debridement and retention of the prosthetic joint should be considered in patients with a 
short duration of symptoms in the absence of implant loosening and soft tissue damage 
where antibiotics with biofilm activity are available (Laffer, et al. 2006, Matthews, et al. 2009, 
Trampuz & Zimmerli 2008, Zimmerli, et al. 2004). 
6. Conclusion  
Prosthetic joint infections involve a complex interplay between the biofilm forming 
microorganisms, host responses and the implant. These infections are an uncommon but 
devastating complication of arthroplasty. However with given the ageing population the 
number of patients requiring arthroplasty is set to increase exponentially. Clinical 
investigation is imperative to increase understanding, improve diagnosis, optimise 
treatment and ultimately prevent prosthetic joint infections. While 2-stage exchanges 
remains the most reliable and consistent treatment option in terms of successful outcomes, 
the advent of more accurate diagnostic tools and combining the use of newer antibiotic 
agents with debridement and retention of the prosthetic joint should be considered a viable 
treatment option rather than an alternative. However this works best where a clear 
treatment protocol has been established, that targets patients at the earliest onset of 
symptoms, where debridement is aggressive and treatment involves is a combined 
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approach between infectious Diseases Physicians and Orthopaedic Surgeons. Results at our 
institution attest to the success of such a protocol. 
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